- Home
- VCEL vs SENS Comparison
VCEL vs SENS Comparison
Compare VCEL & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SENS
- Stock Information
- Founded
- VCEL 1989
- SENS 1996
- Country
- VCEL United States
- SENS United States
- Employees
- VCEL N/A
- SENS N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SENS Industrial Machinery/Components
- Sector
- VCEL Health Care
- SENS Industrials
- Exchange
- VCEL Nasdaq
- SENS Nasdaq
- Market Cap
- VCEL 2.1B
- SENS 396.0M
- IPO Year
- VCEL 1997
- SENS N/A
- Fundamental
- Price
- VCEL $40.15
- SENS $0.50
- Analyst Decision
- VCEL Strong Buy
- SENS Strong Buy
- Analyst Count
- VCEL 8
- SENS 3
- Target Price
- VCEL $62.00
- SENS $1.70
- AVG Volume (30 Days)
- VCEL 430.8K
- SENS 6.4M
- Earning Date
- VCEL 07-31-2025
- SENS 08-07-2025
- Dividend Yield
- VCEL N/A
- SENS N/A
- EPS Growth
- VCEL 521.85
- SENS N/A
- EPS
- VCEL 0.05
- SENS N/A
- Revenue
- VCEL $238,541,000.00
- SENS $23,682,000.00
- Revenue This Year
- VCEL $23.03
- SENS $60.14
- Revenue Next Year
- VCEL $24.52
- SENS $36.55
- P/E Ratio
- VCEL $705.61
- SENS N/A
- Revenue Growth
- VCEL 14.80
- SENS 1.64
- 52 Week Low
- VCEL $37.39
- SENS $0.25
- 52 Week High
- VCEL $63.00
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- VCEL 44.33
- SENS 42.01
- Support Level
- VCEL $40.53
- SENS $0.45
- Resistance Level
- VCEL $43.57
- SENS $0.51
- Average True Range (ATR)
- VCEL 1.62
- SENS 0.02
- MACD
- VCEL -0.16
- SENS 0.00
- Stochastic Oscillator
- VCEL 28.65
- SENS 38.60
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.